今年是中国与乌拉圭建交35周年，也是“一带一路”倡议提出10周年，在此背景下，华大基因将与乌拉圭共同努力，为“一带一路”贡献华大力量。
近日，华大基因成立了乌拉圭子公司，并建设了其在拉丁美洲的第一家中心实验室，致力于将无创产前基因检测、单基因遗传病携带者筛查、新生儿疾病检测、遗传性肿瘤基因检测、传感染病检测等“中国技术”带到拉美市场，从生育健康、肿瘤防控、传感染疾病防控等领域，助力乌拉圭及拉美地区精准医学和公共卫生服务发展。
作为中国基因行业的奠基者，华大基因秉承“基因科技造福人类”的使命，通过20多年的人才积聚、科研积累和产业积淀，立足技术先进、配置齐全和规模领先的多组学产出平台，已成为全球屈指可数的科学技术服务提供商和精准医疗服务运营商。
华大基因致力于通过基因检测、质谱检测、生物信息分析等多组学大数据技术手段，为科研机构、企事业单位、医疗机构、社会卫生组织等提供研究服务和精准医学检测综合解决方案，已形成“覆盖全国、辐射全球”的网络布局，业务遍及全球100多个国家和地区。
BGI Genomics Opens First South America Laboratory
2023 marks the 35th anniversary of diplomatic relations between China and Uruguay and also the 10th anniversary of the Belt and Road initiative. In this context, BGI Genomics aims to help Uruguay and Latin America advance precision medicine and public health initiatives in areas like reproductive health, tumor prevention and control, and infectious disease prevention and management to contribute to the Belt and Road initiative.
BGI Genomics has established a branch in Uruguay and is building its first central laboratory in Latin America. The company's future efforts will center on introducing the latest technology to the Latin American market, such as non-invasive prenatal testing, screening for single-gene hereditary disease carriers, newborn disease testing, and genetic testing for hereditary tumors and infectious diseases.
BGI Genomics, the founding and leading company for the biotechnology sector in China, has remained true to its mission of "Omics for All," growing to become one of the top suppliers of science and technology services globally.
The Shenzhen-based company, which has more than 20 years of experience in scientific research and industrial know-how, relies on its multi-omics output and boasts cutting-edge technology, full configuration on a global scale.
Through the use of multi-omics big data technologies, such as genetic testing, mass spectrometry testing, and bioinformatics analysis, BGI Genomics is committed to offering research services and comprehensive solutions such as precision medical testing for research institutions, businesses, public and medical institutions, social health organizations.
BGI Genomics has developed a national business network with branches across China and over 100 countries worldwide.